Literature DB >> 8939141

Use of interferon beta 1b for multiple sclerosis. Manufacturer defends the drug.

P N Longthorne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8939141      PMCID： PMC2352578          DOI： 10.1136/bmj.313.7067.1263a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Why interferon beta 1b was licensed is a mystery.

Authors:  P Harvey
Journal:  BMJ       Date:  1996-08-03

2.  Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis.

Authors:  M Filippi; M A Horsfield; S P Morrissey; D G MacManus; P Rudge; W I McDonald; D H Miller
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

3.  Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images.

Authors:  M A van Walderveen; F Barkhof; O R Hommes; C H Polman; H Tobi; S T Frequin; J Valk
Journal:  Neurology       Date:  1995-09       Impact factor: 9.910
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.